Evidence map›Paper›PMID 42095963›Full record

ArticleSleep & breathing = Schlaf & Atmung2026

Evaluation of apap parameters in one to three nights titration for final pressure decision-making in a real world clinical setting.

Jesús Escribá-Alepuz, Lidia Herrero, Alberto Saura, Amparo Lloris, Oldar Cercas, José Segrelles, Jorge Pinel, Marta Palop, Gemma Ramos, Estefania Estévez and 1 more

Abstract read
In one paragraph

Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jesús Escribá-AlepuzNeurophysiology Unit, Sagunto Hospital, Valencia, Spain. escriba_jes@gva.es.ORCID http://orcid.org/0000-0002-4197-3293
Lidia HerreroNational Center for Epidemiology, Carlos III Health Institute, Madrid, Spain.
Alberto SauraPneumology Unit, Sagunto Hospital, Valencia, Spain.
Amparo LlorisPneumology Unit, Sagunto Hospital, Valencia, Spain.
Oldar CercasAir Liquide, Valencia, Spain.
José SegrellesAir Liquide, Valencia, Spain.
Jorge PinelPneumology Unit, Sagunto Hospital, Valencia, Spain.
Marta PalopPneumology Unit, Sagunto Hospital, Valencia, Spain.
Gemma RamosAir Liquide, Valencia, Spain.
Estefania EstévezDepartment of Health Psychology, Miguel Hernandez University (MHU), Elche, Spain. eestevez@umh.es.
F Javier PuertasSleep Unit, La Ribera University Hospital - FISABIO, Valencia, Spain. fj.puertas@ucv.es.ORCID http://orcid.org/0000-0002-9341-8160

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCompare pressure values obtained from APAP titration with the final pressure (PF) selected by the clinician to approximate and optimize as much as possible our OSA patients treatment management.

methodsRetrospective descriptive study in 114 OSA treated patients. After 2-3 months with empiric CPAP pressure, they underwent 2-3 nights with 2 different APAP devices to help clinicians to decide an APAP pressure according to percentile 95 (P95) and median (Pm) values after visual analysis. We selected 60 patients (30 for each device) meeting the inclusion criteria until our 3 months follow-up consultation when, according to clinical outcomes, final pressure (PF) is established. Data analysis was blind and random, by an experienced and independent sleep physician and how and why the clinicians used the APAP was statistically evaluated, measuring parameters from each device for every patient and combination of nights and comparing them with PF, whose correlation with AHI was also analyzed.

resultsWe found only significant evidence (p < 0.05) using Pm and Resmed device and considering AHI as a compliance predictive value, but no statistical difference (p > 0.05) performing more than one APAP night.

conclusionsA single night of APAP titration and use of the median pressure may suffice to determine an optimal fixed CPAP setting in our patients. We discuss limitations including small sample size, exclusion of unstable patients and absence of laboratory PSG comparison and Spanish-specific practice patterns.

Indexed as

Clinical Decision-MakingContinuous Positive Airway PressureSleep Apnea, ObstructiveAdultFemaleHumansMaleMiddle AgedPolysomnographyRetrospective StudiesAPAPAuto-titrationCPAPOSA

Identifiers

PMID42095963
PMCPMC13152995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.